These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18941213)

  • 1. Automated identification of complementarity determining regions (CDRs) reveals peculiar characteristics of CDRs and B cell epitopes.
    Ofran Y; Schlessinger A; Rost B
    J Immunol; 2008 Nov; 181(9):6230-5. PubMed ID: 18941213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational identification of antigen-binding antibody fragments.
    Burkovitz A; Leiderman O; Sela-Culang I; Byk G; Ofran Y
    J Immunol; 2013 Mar; 190(5):2327-34. PubMed ID: 23359499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural consensus among antibodies defines the antigen binding site.
    Kunik V; Peters B; Ofran Y
    PLoS Comput Biol; 2012; 8(2):e1002388. PubMed ID: 22383868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitome: database of structure-inferred antigenic epitopes.
    Schlessinger A; Ofran Y; Yachdav G; Rost B
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D777-80. PubMed ID: 16381978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of nested neutralizing and non-neutralizing B cell epitopes on ricin toxin's enzymatic subunit.
    Rudolph MJ; Vance DJ; Cassidy MS; Rong Y; Shoemaker CB; Mantis NJ
    Proteins; 2016 Aug; 84(8):1162-72. PubMed ID: 27159829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staged heterogeneity learning to identify conformational B-cell epitopes from antigen sequences.
    Ren J; Song J; Ellis J; Li J
    BMC Genomics; 2017 Mar; 18(Suppl 2):113. PubMed ID: 28361709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational characterization of B-cell epitopes.
    Rubinstein ND; Mayrose I; Halperin D; Yekutieli D; Gershoni JM; Pupko T
    Mol Immunol; 2008 Jul; 45(12):3477-89. PubMed ID: 18023478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of B-cell epitopes in antibody:protein complexes.
    Kringelum JV; Nielsen M; Padkjær SB; Lund O
    Mol Immunol; 2013 Jan; 53(1-2):24-34. PubMed ID: 22784991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cation-π, amino-π, π-π, and H-bond interactions stabilize antigen-antibody interfaces.
    Dalkas GA; Teheux F; Kwasigroch JM; Rooman M
    Proteins; 2014 Sep; 82(9):1734-46. PubMed ID: 24488795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEASE: predicting B-cell epitopes utilizing antibody sequence.
    Sela-Culang I; Ashkenazi S; Peters B; Ofran Y
    Bioinformatics; 2015 Apr; 31(8):1313-5. PubMed ID: 25432167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computational approach for studying antibody-antigen interactions without prior structural information: the anti-testosterone binding antibody as a case study.
    Koivuniemi A; Takkinen K; Nevanen T
    Proteins; 2017 Feb; 85(2):322-331. PubMed ID: 27936519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-Antibody Complexes.
    Kapingidza AB; Kowal K; Chruszcz M
    Subcell Biochem; 2020; 94():465-497. PubMed ID: 32189312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
    Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
    PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis.
    Wang X; Singh SK; Kumar S
    Pharm Res; 2010 Aug; 27(8):1512-29. PubMed ID: 20422267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Significance and Implications of Antibody Numbering and Antigen-Binding Surface/Residue Definition.
    Dondelinger M; Filée P; Sauvage E; Quinting B; Muyldermans S; Galleni M; Vandevenne MS
    Front Immunol; 2018; 9():2278. PubMed ID: 30386328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope distribution in ordered and disordered protein regions. Part B - Ordered regions and disordered binding sites are targets of T- and B-cell immunity.
    Pavlović MD; Jandrlić DR; Mitić NS
    J Immunol Methods; 2014 May; 407():90-107. PubMed ID: 24726865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of residues in discontinuous B-cell epitopes using protein 3D structures.
    Haste Andersen P; Nielsen M; Lund O
    Protein Sci; 2006 Nov; 15(11):2558-67. PubMed ID: 17001032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.